» Articles » PMID: 38968577

LncRNA DANCR Promotes Macrophage Lipid Accumulation Through Modulation of Membrane Cholesterol Transporters

Overview
Specialty Geriatrics
Date 2024 Jul 5
PMID 38968577
Authors
Affiliations
Soon will be listed here.
Abstract

The progression of atherosclerosis (AS), the pathological foundation of coronary artery disease (CAD), is featured by massive lipid deposition in the vessel wall. LncRNAs are implicated in lipid disorder and AS, whereas the specific role of lncRNA DANCR in atherogenesis remains unknown. Here, we demonstrated that DANCR promotes macrophage lipid accumulation by regulating the expression of membrane cholesterol transport proteins. qPCR showed that compared to control groups, CAD patients and atherosclerotic mice had higher DANCR levels. Treating human THP-1 macrophages and mouse RAW264.7 macrophages with ox-LDL significantly upregulated the expression levels of DANCR. Oil Red O staining showed that the silence of DANCR robustly reduced, while overexpression of DANCR significantly increased the numbers and size of lipid droplets in ox-LDL-treated THP-1 macrophages. In contrast, the opposite phenomena were observed in DANCR overexpressing cells. The expression of ABCA1, ABCG1, SR-BI, and NBD-cholesterol efflux was increased obviously by DANCR inhibition and decreased by DANCR overexpression, respectively. Furthermore, transfection with DANCR siRNA induced a robust decrease in the levels of CD36, SR-A, and Dil-ox-LDL uptake, while DANCR overexpression amplified the expression of CD36, SR-A and the uptake of Dil-ox-LDL in lipid-laden macrophages. Lastly, we found that the effects of DANCR on macrophage lipid accumulation and the expression of membrane cholesterol transport proteins were not likely related to miR-33a. The present study unraveled the adverse role of DANCR in foam cell formation and its relationship with cholesterol transport proteins. However, the competing endogenous RNA network underlying these phenomena warrants further exploration.

References
1.
Ouimet M, Ediriweera H, Afonso M, Ramkhelawon B, Singaravelu R, Liao X . microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis. Arterioscler Thromb Vasc Biol. 2017; 37(6):1058-1067. PMC: 5494696. DOI: 10.1161/ATVBAHA.116.308916. View

2.
Lin C, Lin F, Ho L, Tsai C, Cheng S, Wu W . PKCδ signalling regulates SR-A and CD36 expression and foam cell formation. Cardiovasc Res. 2012; 95(3):346-55. DOI: 10.1093/cvr/cvs189. View

3.
Zhao Z, de Beer M, Cai L, Asmis R, de Beer F, de Villiers W . Low-density lipoprotein from apolipoprotein E-deficient mice induces macrophage lipid accumulation in a CD36 and scavenger receptor class A-dependent manner. Arterioscler Thromb Vasc Biol. 2004; 25(1):168-73. DOI: 10.1161/01.ATV.0000149145.00865.d9. View

4.
Pei C, Fei K, Yuan X, Gong X . LncRNA DANCR aggravates the progression of ovarian cancer by downregulating UPF1. Eur Rev Med Pharmacol Sci. 2019; 23(24):10657-10663. DOI: 10.26355/eurrev_201912_19763. View

5.
Rader D, Hovingh G . HDL and cardiovascular disease. Lancet. 2014; 384(9943):618-625. DOI: 10.1016/S0140-6736(14)61217-4. View